[ Thu, Dec 17th 2020 ]: WOPRAI
[ Thu, Dec 17th 2020 ]: WOPRAI
[ Thu, Dec 17th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Wed, Dec 16th 2020 ]: WOPRAI
[ Tue, Dec 15th 2020 ]: WOPRAI
[ Tue, Dec 15th 2020 ]: WOPRAI
[ Tue, Dec 15th 2020 ]: WOPRAI
Vamil Divan Initiated (ACAD) at Strong Buy and Held Target at $69 on, Dec 16th, 2020
- 🞛 This publication is a summary or evaluation of another publication
Vamil Divan of Mizuho, Initiated "ACADIA Pharmaceuticals Inc." (ACAD) at Strong Buy and Held Target at $69 on, Dec 16th, 2020.
Vamil has made no other calls on ACAD in the last 4 months.
There is 1 other peer that has a rating on ACAD. Out of the 1 peers that are also analyzing ACAD, 0 agree with Vamil's Rating of Hold.
This is the rating of the analyst that currently disagrees with Vamil
- Danielle Brill of "Raymond James" Upgraded from Buy to Strong Buy and Held Target at $65 on, Monday, November 16th, 2020